Scarica l'app Stockscreener
1.64
0.61%
-0.01
Precedente Chiudi:
$1.65
Aprire:
$1.65
Volume 24 ore:
146.24K
Relative Volume:
0.27
Capitalizzazione di mercato:
$85.80M
Reddito:
$21.05M
Utile/perdita netta:
$-89.22M
Rapporto P/E:
-0.9162
EPS:
-1.79
Flusso di cassa netto:
$-64.50M
1 W Prestazione:
+1.23%
1M Prestazione:
-3.53%
6M Prestazione:
-24.77%
1 anno Prestazione:
-72.89%
Intervallo 1D:
$1.60
$1.70
Intervallo di 1 settimana:
$1.60
$1.78
Portata 52W:
$1.02
$6.38
Tscan Therapeutics Inc Stock (TCRX) Company Profile
Nome
Tscan Therapeutics Inc
Settore
Industria
Telefono
857-399-9500
Indirizzo
880 WINTER STREET, WALTHAM
Confronta TCRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
1.64 | 97.90M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-16 | Iniziato | BTIG Research | Buy |
| 2024-05-13 | Iniziato | Needham | Buy |
| 2023-06-22 | Iniziato | Wedbush | Outperform |
Tscan Therapeutics Inc Borsa (TCRX) Ultime notizie
Identifying reversal signals in TScan Therapeutics Inc.Strategy Chart for Real-Time Trade Flow - Newser
Detecting price anomalies in TScan Therapeutics Inc. with AIReversal Pattern Insights with Entry Tips - Newser
How high can TScan Therapeutics Inc. stock goQuick Profit Setup with Signal Forecast - Newser
Published on: 2025-08-10 00:02:03 - Newser
TScan Therapeutics Inc. stock trend forecastSwing Trade Timing with Daily Forecast - Newser
What Fibonacci levels say about TScan Therapeutics Inc. reboundFree Expert Verified Stock Trade Ideas - Newser
Measuring TScan Therapeutics Inc.’s beta against major indicesTrade Ideas Based on Fundamental Metrics - Newser
Published on: 2025-08-09 20:27:19 - Newser
TScan Therapeutics Inc. Stock Support and Resistance Levels You Should KnowInsider Strategy for High Conviction Picks - Newser
What recovery options are there for TScan Therapeutics Inc.Downside Control Plan With Support Analysis - Newser
Custom strategy builders for tracking TScan Therapeutics Inc.Sector Rotation and Stock Opportunity Analysis - Newser
TScan Therapeutics (TCRX) Expected to Announce Quarterly Earnings on Monday - Defense World
What moving averages say about TScan Therapeutics Inc.2-Day Signal Watch with Forecast Outcome - Newser
TScan Therapeutics TCRX 2025Q2 Earnings Preview Downside Risk Amid Revenue Pressure - AInvest
How TScan Therapeutics Inc. stock performs during market volatilityCapital Growth Plan for New Investors - Newser
Order flow analysis tools used on TScan Therapeutics Inc.Free High Yield Stock Screening Results - Newser
Real time alert setup for TScan Therapeutics Inc. performanceSwing Trade Signal and Price Prediction - Newser
Visualizing TScan Therapeutics Inc. stock with heatmapsStrategy Chart for Real-Time Trade Flow - Newser
Why TScan Therapeutics Inc. stock attracts strong analyst attentionReal Time Stock Movement and Alerts - Newser
Is it the right time to buy TScan Therapeutics Inc. stockStrong return on assets - Jammu Links News
What are the latest earnings results for TScan Therapeutics Inc.Extraordinary market timing - Jammu Links News
How strong is TScan Therapeutics Inc. company’s balance sheetAchieve superior returns with professional insights - Jammu Links News
How does TScan Therapeutics Inc. compare to its industry peersPhenomenal returns - Jammu Links News
TScan Therapeutics Inc. Stock Analysis and ForecastCapitalize on momentum-driven investment opportunities - Jammu Links News
TScan Therapeutics, Inc. (NASDAQ:TCRX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Evaluating TScan Therapeutics Inc. with trendline analysisReversal Signal Prediction Based on Volume - Newser
When is TScan Therapeutics Inc. stock expected to show significant growthCapitalize on stocks with high profit margins - Jammu Links News
Is TScan Therapeutics Inc. a good long term investmentRapid wealth multiplication - Jammu Links News
What makes TScan Therapeutics Inc. stock price move sharplyMaximize gains with data-driven trading alerts - Jammu Links News
What are the technical indicators suggesting about TScan Therapeutics Inc.Maximize your portfolio’s growth potential - Jammu Links News
Can TScan Therapeutics Inc. rally from current levelsAsset Allocation Summary With Future Outlook - Newser
What is the dividend policy of TScan Therapeutics Inc. stockFree Stock Ideas For Smart Trading - Jammu Links News
Should you hold or exit TScan Therapeutics Inc. nowEntry Zone Watchlist With Momentum Focus - Newser
TScan Therapeutics, Inc. Trade Ideas — BOATS:TCRX - TradingView
What machine learning models say about TScan Therapeutics Inc.Free AI Driven Buy Alert Trade Blueprint - Newser
Tscan Therapeutics Inc Azioni (TCRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
3.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):